1. Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med. 2012; 10:138.
2. Hamaguchi M, Kojima T, Ohbora A, Takeda N, Fukui M, Kato T. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World J Gastroenterol. 2012; 18:156–167.
3. Park YW, Min SK, Lee JH. Relationship between lower urinary tract symptoms/benign prostatic hyperplasia and metabolic syndrome in Korean men. World J Mens Health. 2012; 30:183–188.
4. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112:2735–2752.
5. Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes. 2010; 1:36–47.
6. Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Fernández-Labandera C, Cabrera M, Sáinz JC, et al. Ibermutuamur Cardiovascular Risk Assessment (ICARIA) Study Group. Occupation-related differences in the prevalence of metabolic syndrome. Diabetes Care. 2008; 31:1884–1885.
7. Myong JP, Kim HR, Jung-Choi K, Baker D, Choi B. Disparities of metabolic syndrome prevalence by age, gender and occupation among Korean adult workers. Ind Health. 2012; 50:115–122.
8. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109:433–438.
9. Olefsky JM, Saltiel AR. PPAR gamma and the treatment of insulin resistance. Trends Endocrinol Metab. 2000; 11:362–368.
10. American Diabetes Association. Consensus Development Conference on Insulin Resistance. 5-6 November 1997. Diabetes Care. 1998; 21:310–314.
11. Slama M, Susic D, Frohlich ED. Prevention of hypertension. Curr Opin Cardiol. 2002; 17:531–536.
12. Baik I, Shin C. Prospective study of alcohol consumption and metabolic syndrome. Am J Clin Nutr. 2008; 87:1455–1463.
13. Yokoyama H, Hiroshi H, Ohgo H, Hibi T, Saito I. Effects of excessive ethanol consumption on the diagnosis of the metabolic syndrome using its clinical diagnostic criteria. Intern Med. 2007; 46:1345–1352.
14. Rosell M, De Faire U, Hellénius ML. Low prevalence of the metabolic syndrome in wine drinkers--is it the alcohol beverage or the lifestyle. Eur J Clin Nutr. 2003; 57:227–234.
15. Gigleux I, Gagnon J, St-Pierre A, Cantin B, Dagenais GR, Meyer F, et al. Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome. J Nutr. 2006; 136:3027–3032.
16. Djoussé L, Arnett DK, Eckfeldt JH, Province MA, Singer MR, Ellison RC. Alcohol consumption and metabolic syndrome: does the type of beverage matter? Obes Res. 2004; 12:1375–1385.
17. Freiberg MS, Cabral HJ, Heeren TC, Vasan RS, Curtis Ellison R. Third National Health and Nutrition Examination Survey. Alcohol consumption and the prevalence of the Metabolic Syndrome in the US.: a cross-sectional analysis of data from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2004; 27:2954–2959.
18. Nakanishi N, Takatorige T, Suzuki K. Cigarette smoking and the risk of the metabolic syndrome in middle-aged Japanese male office workers. Ind Health. 2005; 43:295–301.
19. Miyatake N, Wada J, Kawasaki Y, Nishii K, Makino H, Numata T. Relationship between metabolic syndrome and cigarette smoking in the Japanese population. Intern Med. 2006; 45:1039–1043.
20. Geslain-Biquez C, Vol S, Tichet J, Caradec A, D'Hour A, Balkau B. D.E.S.I.R. Study Group. The metabolic syndrome in smokers. The D.E.S.I.R. study. Diabetes Metab. 2003; 29:226–234.
21. Cena H, Fonte ML, Turconi G. Relationship between smoking and metabolic syndrome. Nutr Rev. 2011; 69:745–753.